Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme - Test2 - elhamkhani - TriplyDB

Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme

Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme

http://www.wikidata.org/entity/Q35127937

about

Plasmid-mediated quinolone resistance: a multifaceted threat Analysis of drug resistance determinants in Klebsiella pneumoniae isolates from a tertiary-care hospital in Beijing, China Structural diversity of class 1 integrons and their associated gene cassettes in Klebsiella pneumoniae isolates from a hospital in China The growing burden of antimicrobial resistance.Emergence of human pandemic O25:H4-ST131 CTX-M-15 extended-spectrum-beta-lactamase-producing Escherichia coli among companion animals.Limited transmission of bla(CTX-M-9)-type-positive Escherichia coli between humans and poultry in Vietnam.Fecal carriage of CTX-M β-lactamase-producing Enterobacteriaceae in nursing homes in the Kinki region of Japan.Prevalence and molecular characterization of extended-spectrum β-lactamase (ESBL) and plasmidic AmpC β-lactamase (pAmpC) producing Escherichia coli in dogs.Cholera outbreaks in Nigeria are associated with multidrug resistant atypical El Tor and non-O1/non-O139 Vibrio cholerae.Transformation of N-phenylpiperazine by mixed cultures from a municipal wastewater treatment plant Predictive analysis of transmissible quinolone resistance indicates Stenotrophomonas maltophilia as a potential source of a novel family of Qnr determinants Genetic diversity of Salmonella enteric serovar typhi and paratyphi in Shenzhen, China from 2002 through 2007 Molecular epidemiology of metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates from Norway and Sweden shows import of international clones and local clonal expansion Unique Features of Aeromonas Plasmid pAC3 and Expression of the Plasmid-Mediated Quinolone Resistance Genes Characteristics of Escherichia coli sequence type 131 isolates that produce extended-spectrum β-lactamases: global distribution of the H30-Rx sublineage.Carbapenem-resistant Klebsiella pneumoniae strains exhibit diversity in aminoglycoside-modifying enzymes, which exert differing effects on plazomicin and other agents.Isolation of Escherichia coli strains with AcrAB-TolC efflux pump-associated intermediate interpretation or resistance to fluoroquinolone, chloramphenicol and aminopenicillin from dogs admitted to a university veterinary hospital Antibiotics and bacterial resistance in the 21st century.The characterization and antibiotic resistance profiles of clinical Escherichia coli O25b-B2-ST131 isolates in Kuwait Prevalence of plasmid-mediated quinolone resistance genes among ciprofloxacin-nonsusceptible Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in Korea Antibiotic-resistant Escherichia coli bacteria, including strains with genes encoding the extended-spectrum beta-lactamase and QnrS, in waterbirds on the Baltic Sea Coast of Poland Epidemiology of plasmid-mediated quinolone resistance in salmonella enterica serovar typhimurium isolates from food-producing animals in Japan.Antibiotic resistance in uropathogenic e. Coli strains isolated from non-hospitalized patients in pakistan.Type II and type IV topoisomerase mutations in clinical isolates of Morganella morganii harbouring the qnrD gene.Characterization of fluoroquinolone-resistant Shigella flexneri in Hangzhou area of China.A high throughput multiplex PCR assay for simultaneous detection of seven aminoglycoside-resistance genes in Enterobacteriaceae.Molecular characterization of multidrug-resistant extended-spectrum β-lactamase-producing Enterobacteriaceae isolated in Antananarivo, Madagascar.Analysis for prevalence and physical linkages amongst integrons, ISEcp1, ISCR1, Tn21 and Tn7 encountered in Escherichia coli strains from hospitalized and non-hospitalized patients in Kenya during a 19-year period (1992-2011).Cross-sectional study on prevalence and molecular characteristics of plasmid mediated ESBL/AmpC-producing Escherichia coli isolated from veal calves at slaughter.Plasmid-mediated quinolone resistance.Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.First characterization of CTX-M-15-producing Escherichia coli ST131 and ST405 clones causing community-onset infections in South America.Comparison of ESBL--and AmpC producing Enterobacteriaceae and methicillin-resistant Staphylococcus aureus (MRSA) isolated from migratory and resident population of rooks (Corvus frugilegus) in Austria A degenerate PCR-based strategy as a means of identifying homologues of aminoglycoside and β-lactam resistance genes in the gut microbiota.Extended-spectrum-beta-lactamases, AmpC beta-lactamases and plasmid mediated quinolone resistance in klebsiella spp. from companion animals in Italy.Emergence of extended-spectrum beta-lactamase (CTX-M-15 and CTX-M-14)-producing nontyphoid Salmonella with reduced susceptibility to ciprofloxacin among food animals and humans in Korea.Quinolone resistance mechanisms among extended-spectrum beta-lactamase (ESBL) producing Escherichia coli isolated from rivers and lakes in Switzerland.Multiresistant extended-spectrum β-lactamase-producing Enterobacteriaceae from humans, companion animals and horses in central Hesse, Germany Non-phenotypic tests to detect and characterize antibiotic resistance mechanisms in Enterobacteriaceae.Molecular epidemiology and genetic diversity of fluoroquinolone-resistant Escherichia coli isolates from patients with community-onset infections in 30 Chinese county hospitals

P2860

Q24645356-64EF30F4-84AB-4B96-9396-055EA60B8D91 Q28481714-F3EBD246-E902-4D89-9382-9B203DB0C977 Q28533900-CDF550FE-F910-4ED3-A7EA-CE4A33DDE904 Q30371239-1342A1C5-C3FE-400D-BD05-198171BCFB9F Q30385107-EEA5B7CD-E2ED-4D58-8225-611C50674B45 Q30386767-C41A61E9-EAA8-4287-A21D-2CCB0B29E41F Q30393407-868F6909-885A-40AC-803E-A871D21DA9E6 Q30401450-FCB810E0-2817-4611-BBD9-1A41B4787415 Q30427821-76F795F0-A59D-4CCB-8139-E9171569673B Q31168336-1C20281C-9516-4B92-AB4B-0BC8A1939970 Q33369591-702AD255-F3A7-46EF-9F65-B48DF9AC646C Q33527574-CC0AA9DB-C1B7-4AFF-9F45-9CBB36939E83 Q33559180-58D497EA-BA1C-40E8-B421-5DD7B5C8A7A7 Q33726354-3273D357-13D3-4962-A44B-B87E70AE625C Q33798233-4E150108-6FBA-4FCE-8837-CE1D8C3F2DD1 Q34058006-CC09064B-4DD1-4D9C-84F4-915C278D5D9E Q34085440-B2377087-56A7-43D5-9024-6D4C09876208 Q34156349-DE9472DA-23AC-4E18-96AB-D32450DDAECE Q34157129-772CAC71-C064-4913-B3A9-EF25E3AC5DF7 Q34238560-DBEC26AA-AFFA-4B30-9390-6B2FEF24E298 Q34432199-AE98BD12-454E-4278-A0C6-17C55DED5FB3 Q34477960-9DE13492-D747-4663-8FE9-3CF8F57952C0 Q34479623-EF1317AD-AADE-451C-901D-37536E947692 Q34538010-61267ECC-6547-44CE-9F4C-39F11BBBBACE Q34605549-CA31C91D-02B4-4C7E-9EE6-F4CA861E5FBB Q34622837-F26782DB-3405-4F31-AE09-1AA03580369C Q34675362-ADF32A23-225F-4AFE-A7B9-CC59FD11CE4B Q34727309-7AD769AE-5C88-46CB-AD8E-DAD6DB36B965 Q34750125-6E033C21-3A02-4DCC-B338-74C23277A889 Q34888920-08D3CA8E-AE30-4ADC-B54A-43C0654D268A Q35007624-73EA0416-1FEF-4936-88E5-D7DF48D34B41 Q35066516-29EDFE24-11C9-45FF-BE5C-19FBD42963B3 Q35082753-CC34EA5C-DEF8-4236-A3CA-02E9D9F3916E Q35086954-E0ACF6C7-658A-4FCE-A3E1-0000294EBE5B Q35111248-7976C265-6853-413E-AF6E-66953426D5A9 Q35140199-E7B6E838-9BF4-40A3-ADD5-277F86BF410B Q35155107-99294873-E387-44B7-B507-70A036AB7C6A Q35205641-6053450D-1406-4568-84E2-3207F614E28D Q35297743-7DE980CE-1784-40EA-8C70-DF59D8AA6162 Q35331113-D1AACFE4-2D11-48CD-A568-1C5CFBA0501C

P2860

Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme

http://www.wikidata.org/entity/Q35127937

description

2006 nî lūn-bûn

@nan

2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Prevalence in the United State ...... ciprofloxacin-modifying enzyme

@ast

Prevalence in the United State ...... ciprofloxacin-modifying enzyme

@en

type

label

Prevalence in the United State ...... ciprofloxacin-modifying enzyme

@ast

Prevalence in the United State ...... ciprofloxacin-modifying enzyme

@en

prefLabel

Prevalence in the United State ...... ciprofloxacin-modifying enzyme

@ast

Prevalence in the United State ...... ciprofloxacin-modifying enzyme

@en

P1433

Q35127937-F6416998-115A-4CEB-9EED-95429C75E250

P1476

Q35127937-46E4C855-1D60-4CF5-8641-B2125064582B

P2093

Q35127937-1B5CC536-0FB9-44FC-BD72-2DD54C6775DC

Q35127937-91CE6BBC-D605-434C-B1EE-D1A8B8AC27F6

Q35127937-9363077D-3E23-4C15-BDBE-7A82ADBDABAD

Q35127937-D1E91822-0859-489D-BC4B-408FCE7279BC

Q35127937-EFEC3DD7-9094-4842-9155-267A181E8A3D

P2860

Q35127937-09418250-7CC5-4BEF-9BA7-E57213610B47

Q35127937-1ED922D9-59A4-4E45-802D-FC5C10C79C64

Q35127937-22426B47-7A7B-435F-9003-0A62513C8ED9

Q35127937-5AB4401A-DE28-42E8-9891-0098F9A3CC8F

Q35127937-6F30CDC6-027C-494C-AC30-9B600F729F22

Q35127937-7FBA3AAB-7647-4AA1-B5BF-E5981DF2257A

Q35127937-87C76CF3-B0BD-450C-8434-036C7873624A

Q35127937-91410AE3-3E3B-42E3-85D1-732CA53270AC

Q35127937-B8F3568E-90F7-4FE0-9E7A-35B38EE7FED3

Q35127937-D9413BDB-B7A5-4473-8420-59406F84D8C6

P304

Q35127937-363F2EEB-954B-41C1-9C96-597C65E99E70

P31

Q35127937-ED610317-91CB-4722-9AA9-DC64B6AE28B9

P356

Q35127937-468FABD7-3F81-4BBB-9CB8-08A293441ECF

P407

Q35127937-27FC96B0-974D-492F-82D4-4FEDE301C584

P433

Q35127937-961C76F8-4973-4178-B681-B17B6E832406

P478

Q35127937-94318E7E-85BC-41CF-A83F-C1B779B78D3F

P577

Q35127937-2182B842-6DB1-4341-99FC-036C479D85BF

P698

Q35127937-4C7868E0-5DAF-49F3-B112-690ABB714DCB

P921

Q35127937-CD6973F0-C42D-4572-B0BB-A8A5E8937E93

P932

Q35127937-DB0614FB-EDBD-42E1-8E31-11EA054D28D5

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Prevalence in the United State ...... ciprofloxacin-modifying enzyme

@en

P2093

Ari Robicsek

http://www.w3.org/2001/XMLSchema#string

Chi Hye Park

http://www.w3.org/2001/XMLSchema#string

Daniel Sahm

http://www.w3.org/2001/XMLSchema#string

David C Hooper

http://www.w3.org/2001/XMLSchema#string

George A Jacoby

http://www.w3.org/2001/XMLSchema#string

P2860

Aminoglycoside 6'-N-acetyltransferase variants of the Ib type with altered substrate profile in clinical isolates of Enterobacter cloacae and Citrobacter freundii.

Mechanism of plasmid-mediated quinolone resistance.

Mechanisms of action and resistance of older and newer fluoroquinolones.

Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae.

qnrB, another plasmid-mediated gene for quinolone resistance

qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States.

Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China.

Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States.

Cloning of a novel gene for quinolone resistance from a transferable plasmid in Shigella flexneri 2b.

Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase.

P304

3953-3955

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00915-06

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P577

2006-09-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16954321

http://www.w3.org/2001/XMLSchema#string

P921

Ameeriga Ütisriigiq

P932

1635235

http://www.w3.org/2001/XMLSchema#string